Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

<ul><li>AEON Biopharma is a clinical-stage, specialty pharmaceutical company developing a Botox biosimilar.</li><li>In partnership with Daewoong, it is conducting analytical work to demonstrate biosimilarity for ABP-450.</li><li>Following a Type 2b meeting with the FDA, we expect 2027 PD & bridging studies to support the Section 351(k) BLA package for approval.</li></ul>

AEON Biopharma is a clinical-stage, specialty pharmaceutical company developing a Botox biosimilar.In partnership with Daewoong, it is conducting analytical work to demonstrate biosimilarity for ABP-450.Following a Type 2b meeting with the FDA, we expect 2027 PD & bridging studies to support the Section 351(k) BLA package for approval.

AEON: Initiating Coverage - Imitation is a Sincere Form of Flattery: Seeking a Botox Biosimilar

United States

AEON Biopharma, Inc. operates as a clinical stage biopharmaceutical company. The Company focuses on developing novel and proprietary treatment paradigms to improve patient outcomes of debilitating medical conditions. AEON Biopharma serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

AEON Biopharma Inc (AEON US)

AEON: Initiating Coverage - Imitation is a Sincere Form of Flattery: Seeking a Botox Biosimilar

AEON Biopharma is a clinical-stage, specialty pharmaceutical company developing a Botox biosimilar. In partnership with Daewoong, it is conducting...

Zacks Small Cap Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)